Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:A Whistleblower Lawsuit Continues to Plague Alger Not Rated 0.0 Email Routing List Email & Route  Print Print
Friday, September 28, 2012

A Whistleblower Lawsuit Continues to Plague Alger

News summary by MFWire's editors

Looks like Fred Alger Management [profile] is still in the legal hot seat. Reuters reports today that the New York fund firm failed to get a whistleblower lawsuit by a former PM dismissed in court.

Alger had attempted to dismiss the lawsuit on the grounds that Ott had "contrived a controversy." But U.S. District Judge Loretta Preska ruled in favor of Rosanne Ott, who ran the Alger Health Sciences fund from 2005 until January 2011 when she was fired. But Preska also dismissed several of Ott's claims.

Ott, also a former U.S. Army Black Hawk helicopter pilot, alleged that Alger instituted a policy in April 2010 applying only to its Ott's fund, allowing other Alger PMs to trade ahead of her fund. When Ott filed a formal complaint with the SEC on Sept. 7, 2010, she was subjected to harassment, replaced as head of Alger's heath care group, and also saw her bonus reduced by 92 percent.

Ott's subsequent lawsuit, filed in June 2011, is one of the first to emerge after 2010 Dodd-Frank financial reforms banned companies from retaliating against whistleblowers. While Preska dismissed nine of Ott's 10 claims — including claims over bonuses and an alleged failure to pay deferred compensation that had not yet vested at the time Ott was fired — she said there was enough evidence that Ott reasonably believed the trading policy was illegal, and that her complaints led to her firing.

 

Edited by: Irene Park


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. MMI Executive IQ - cohort 4, Jun 3-6
  2. 2024 MMI Board of Governors Retreat, Jun 3-5
  3. ICI webinar - Improving Fund Proxy Campaigns — Viewpoints from the Proxy Service Firm, June 4
  4. MFDF Conference of Fund Leaders Forum, June 5
  5. MFDF in-person outreach: Continuing Regulatory Impacts on Fund Boards, June 11
  6. WE Boston - Women In Wine, June 11
  7. IMEA Digital Marketing Roundable, June 12
  8. 2024 MMI Leadership Pathway Seminar, Jun 12-14
  9. 2024 Nicsa Fearless Leadership Symposium, June 12
  10. MFDF webinar - Digital Assets in the Fund Space (Part 1 of 2), June 12
  11. Expect Miracles East Coast Classic 2024, June 13
  12. WE South - Female Finance Connect, June 13
  13. IMEA webinar - Snapshot on the Talent Landscape, June 18
  14. 2024 MMI National Accounts Roundable, June 18
  15. MFDF webinar - Lessons Learned from the Regional Bank Volatility and the Impact on Registered Funds, June 18
  16. MFDF Director Discussion Series - Open Forum (Philadelphia), June 20
  17. New York YPEM Cornhole Classic, June 25
  18. Morningstar Investment Conference Conference 2024, Jun 26-27
  19. 2024 MMI Institutional Roundtable, June 26
  20. WE PNW Seattle - Pickleball and Networking, June 27
  21. MFDF webinar - Mid-Year Tax Update for Registered Investment Companies, July 16
  22. MFDF Director Discussion Series - Open Forum via Zoom, July 17
  23. MFDF Director Discussion Series - Open Forum (New York), July 23
  24. IMEA Portfolio Construction Roundtable, September 19
  25. MFDF Continuing Regulatory Impacts on Fund Boards program, October 15
  26. 2024 MMI Annual Conference, Oct 15-17




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use